Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

This study is ongoing, but not recruiting participants.

First Received on October 15, 2008. Last Updated on July 20, 2011 History of Changes

Sponsor:	Summa Health System
Information provided by:	Summa Health System
ClinicalTrials.gov Identifier:	NCT00773669

Purpose

The primary goal of this retrospective study is to evaluate the male breast cancer patient population at Summa Health System/Akron City Hospital over a period of 18 years and compare the findings to historical data.

The objectives are to:

identify risk factors.
evaluate stage and histology at the time of presentation.
document treatment modalities and outcomes.
analyze outcomes for comparison to historical data.

Condition
Breast Cancer

Study Type:	Observational
Study Design:	Observational Model: Ecologic or Community Time Perspective: Retrospective
Official Title:	Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

Resource links provided by NLM:

Genetics Home Reference related topics: breast cancer

MedlinePlus related topics: Breast Cancer Cancer Male Breast Cancer

U.S. FDA Resources

Further study details as provided by Summa Health System:

Primary Outcome Measures:

Retrospective chart review to evaluate the male breast cancer patient population at Summa Health System/Akron City Hospital over a period of years and compare the findings to historical data. [ Time Frame: Chart review from 1995-2007 ] [ Designated as safety issue: No ]

Estimated Enrollment:	100
Study Start Date:	October 2008
Estimated Study Completion Date:	December 2011
Primary Completion Date:	March 2011 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Males with breast cancer.

Criteria

Inclusion Criteria:

Male breast cancer patients diagnosed and/or treated at Summa Health System/Akron City Hospital from the reference year of 1995 through 2007.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00773669

Sponsors and Collaborators

Summa Health System

Investigators

Principal Investigator:

Gary Williams, MD

Summa Health System

More Information

No publications provided

Responsible Party:	Gary Williams, MD, Summa Health System
ClinicalTrials.gov Identifier:	NCT00773669 History of Changes
Other Study ID Numbers:	Male Breast Cancer
Study First Received:	October 15, 2008
Last Updated:	July 20, 2011
Health Authority:	United States: Institutional Review Board

Keywords provided by Summa Health System:

male breast cancer
Male breast cancer patients diagnosed and/or
treated at Summa Health System/Akron City Hospital
from the reference year of 1995 through 2007.

Additional relevant MeSH terms:

Breast Neoplasms
Breast Neoplasms, Male
Neoplasms by Site

Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on February 09, 2012